Xenon Pharmaceuticals (XENE) Reports Q3 Loss of $0.43
Xenon Pharmaceuticals (NASDAQ: XENE) reported Q3 EPS of ($0.43), versus ($0.51) reported last year.
For earnings history and earnings-related data on Xenon Pharmaceuticals (XENE) click here.
Xenon Pharmaceuticals (NASDAQ: XENE) reported Q3 EPS of ($0.43), versus ($0.51) reported last year.
For earnings history and earnings-related data on Xenon Pharmaceuticals (XENE) click here.